PharmaEngine Statistics

Total Valuation

PharmaEngine has a market cap or net worth of TWD 14.20 billion. The enterprise value is 10.34 billion.

Market Cap	14.20B
Enterprise Value	10.34B

Important Dates

The last earnings date was Friday, March 14, 2025.

Earnings Date	Mar 14, 2025
Ex-Dividend Date	Aug 12, 2024

Share Statistics

PharmaEngine has 143.68 million shares outstanding. The number of shares has increased by 0.13% in one year.

Current Share Class	n/a
Shares Outstanding	143.68M
Shares Change (YoY)	+0.13%
Shares Change (QoQ)	+0.45%
Owned by Insiders (%)	1.27%
Owned by Institutions (%)	3.84%
Float	93.39M

Valuation Ratios

The trailing PE ratio is 8.12 and the forward PE ratio is 31.92.

PE Ratio	8.12
Forward PE	31.92
PS Ratio	5.62
PB Ratio	2.63
P/TBV Ratio	2.63
P/FCF Ratio	31.14
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.01, with an EV/FCF ratio of 22.68.

EV / Earnings	5.91
EV / Sales	4.10
EV / EBITDA	5.01
EV / EBIT	5.04
EV / FCF	22.68

Financial Position

The company has a current ratio of 13.15, with a Debt / Equity ratio of 0.00.

Current Ratio	13.15
Quick Ratio	13.07
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	0.02
Interest Coverage	11,343.46

Financial Efficiency

Return on equity (ROE) is 37.81% and return on invested capital (ROIC) is 27.64%.

Return on Equity (ROE)	37.81%
Return on Assets (ROA)	26.18%
Return on Invested Capital (ROIC)	27.64%
Return on Capital Employed (ROCE)	37.99%
Revenue Per Employee	57.35M
Profits Per Employee	39.80M
Employee Count	44
Asset Turnover	0.51
Inventory Turnover	2.16

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -0.80% in the last 52 weeks. The beta is 0.40, so PharmaEngine's price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-0.80%
50-Day Moving Average	106.29
200-Day Moving Average	95.82
Relative Strength Index (RSI)	37.93
Average Volume (20 Days)	1,052,263

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PharmaEngine had revenue of TWD 2.52 billion and earned 1.75 billion in profits. Earnings per share was 12.17.

Revenue	2.52B
Gross Profit	2.48B
Operating Income	2.05B
Pretax Income	2.16B
Net Income	1.75B
EBITDA	2.05B
EBIT	2.05B
Earnings Per Share (EPS)	12.17

Full Income Statement

Balance Sheet

The company has 3.86 billion in cash and 7.14 million in debt, giving a net cash position of 3.85 billion or 26.82 per share.

Cash & Cash Equivalents	3.86B
Total Debt	7.14M
Net Cash	3.85B
Net Cash Per Share	26.82
Equity (Book Value)	5.40B
Book Value Per Share	37.58
Working Capital	5.38B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 456.73 million and capital expenditures -811,000, giving a free cash flow of 455.92 million.

Operating Cash Flow	456.73M
Capital Expenditures	-811,000
Free Cash Flow	455.92M
FCF Per Share	3.17

Full Cash Flow Statement

Margins

Gross margin is 98.11%, with operating and profit margins of 81.37% and 69.39%.

Gross Margin	98.11%
Operating Margin	81.37%
Pretax Margin	85.72%
Profit Margin	69.39%
EBITDA Margin	81.43%
EBIT Margin	81.37%
FCF Margin	18.07%

Dividends & Yields

This stock pays an annual dividend of 6.00, which amounts to a dividend yield of 6.17%.

Dividend Per Share	6.00
Dividend Yield	6.17%
Dividend Growth (YoY)	-25.00%
Years of Dividend Growth	n/a
Payout Ratio	12.30%
Buyback Yield	-0.13%
Shareholder Yield	6.04%
Earnings Yield	12.34%
FCF Yield	3.21%

Dividend Details

Stock Splits

The last stock split was on July 26, 2017. It was a forward split with a ratio of 1.1999616012.

Last Split Date	Jul 26, 2017
Split Type	Forward
Split Ratio	1.1999616012

Scores

PharmaEngine has an Altman Z-Score of 21.46.

Altman Z-Score	21.46
Piotroski F-Score	n/a